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Purpose: This study was performed to examine the eﬀect of hypercholesterolemia on inducible nitric oxide synthase (NOS-2)
expression and oxidative tissue injury in an experimental rat model of elevated IOP.Methods: Wistar rats were maintained on either
regular chow or a high-cholesterol diet for 24 weeks. Intraocular pressure (IOP) was elevated in hypercholesterolemic rats by uni-
laterally cauterizing three episcleral vessels. Rats were divided into four experimental groups as follows; hypercholesterolemia,
hypercholesterolemia + elevated IOP, elevated IOP and control. NOS-2 distribution, lipid peroxidation and retinal nerve ﬁber layer
(RNFL) thickness was evaluated in all experimental groups at the end of 24 weeks. Results: Light microscopic evaluation of retinas
in hypercholesterolemic rats revealed breaks and discontinuation in focal areas in the outer nuclear layer (ONL). NOS-2 positive
staining was observed throughout the outer plexiform layer (OPL), inner plexiform layer (IPL) and ganglion cell layer (GCL) in
rats with elevated IOP and/or hypercholesterolemia. Calculated values of RNFL thickness in hypercholesterolemic rats were signif-
icantly higher than those in the control and elevated IOP group. Vitreous malondialdehyde (MDA) levels detected in elevated IOP
(3.51 ± 0.31 nmol/mg protein) and hypercholesterolemia + elevated IOP (5.14 ± 1.28 nmol/mg protein) groups were signiﬁcantly
higher than those detected in hypercholesterolemic (1.92 ± 1.43 nmol/mg protein) and control (1.89 ± 0.24 nmol/mg protein) groups.
Conclusion: The presented data conﬁrms hypercholesterolemia as a risk factor in the development of glaucomatous optic neuropathy
(GON) and suggests that increased circulating cholesterol may exacerbate disease progression by inducing NOS-2 expression and
elevating oxidant tissue injury.
 2004 Elsevier Ltd. All rights reserved.
Abbreviations: GCL, ganglion cell layer; GON, glaucomatous optic neuropathy; IOP, intraocular pressure; IPL, inner plexiform layer; MDA,
malondialdehyde; NMDA, N-methyl-D-aspartate; NO, nitric oxide; NOS-2, inducible nitric oxide synthase; O:2 , superoxide; ONL, outer nuclear
layer; ONOO, peroxynitrite; OPL, outer plexiform layer; RNFL, retinal nerve ﬁber layer; ROS, reactive oxygen species; TBA, thiobarbituric acid;
VCL, photoreceptor cell layer
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Glaucoma is a progressive optic neuropathy charac-
terized by optic disc and nerve ﬁber layer damage.
Although the pathophysiological mechanisms leading
to GON remain uncertain, mechanical compression
and vascular ischemia have been suggested to play a
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& Weinreb, 1994). The mechanical compression theory
considers elevated IOP as the most important risk fac-
tor for the disease (Yan, Coloma, & Metheetrairut,
1994). This theory gives support to the essential signs
of glaucomatous optic neuropathy, such as increased
cupping (Greenﬁeld, 1999) and neuroretinal rim thin-
ning (Jonas, Budde, & Lang, 1998) but does not explain
the existence of normal tension glaucoma (Yamamoto
& Kitazawa, 1998). Alternatively, the vascular ischemia
theory supposes that vascular insuﬃciency in the optic
nerve head results in decreased metabolic activity which
subsequently leads to increased glutamate accumulation
and ganglion cell death (Flammer, 1994; Sucher, Lip-
ton, & Dreyer, 1997). Indeed, a large number of studies
have shown a high association between GON and vas-
cular disorders related to hypertension, diabetes and
hypercholesterolemia (Hayreh, Bill, & Sperber, 1994;
Hayreh, Peer, & Zimmerman, 1999; Hennis, Wu, &
Nemesure, 2003; Klein, Klein, & Moss, 1984; McGwin
et al., 2004; Stewart, Sine, Sutherland, & Stewart, 1996;
Tanaka, Yamazaki, & Yokoyama, 2001; Winder,
1977).
Increased glutamate accumulation resulting from
vascular insuﬃciency can reach potentially toxic levels
when released synaptically. Glutamate is an excitatory
neurotransmitter which acts on N-methyl-D-aspartate
(NMDA) receptors located in the plasma membrane
of both neurons and glia (Sucher et al., 1997). Overstim-
ulation of NMDA receptors increases intracellular cal-
cium to toxic levels and activates nitric oxide synthase
(NOS), resulting in excessive nitric oxide (NO) produc-
tion (Montoliu, Llansola, & Monfort, 2001). Nitric
oxide-mediated cytotoxicity and the capacity of NO to
induce apoptosis have been documented in macrophages
(Sarih, Souvannavong, & Adam, 1993) astrocytes (Hu &
Van Eldik, 1996) and neuronal cells (Heneka et al.,
1998). Although the mechanisms of NO-mediated apop-
tosis are not clearly elucidated, the induction of apopto-
sis by NO can be the result of DNA damage which in
turn activates p53 that has been reported to cause apop-
tosis (Kim, Bombeck, & Billiar, 1999).
Nitric oxide exhibits a wide spectrum of functions in
both normal and pathological states. Physiological
amounts of NO synthesized by constitutive NOS iso-
forms (NOS-1 and NOS-3) participates in neurotrans-
mission and cardiovascular signaling (Goldstein,
Ostwald, & Roth, 1996) while excessive amounts of
NO released by NOS-2 (Becquet, Courtois, & Goureau,
1997) results in cytotoxicity via reacting with superoxide
(O:2 ) to form the potent oxidant peroxynitrite
(ONOO) (Beckman, Beckman, & Chen, 1990). Recent
studies have highlighted the role of NO in GON by
reporting the presence of NOS-2 in glaucomatous optic
nerve heads of rat (Shareef, Sawada, & Neufeld, 1999)
and humans (Liu & Neufeld, 2000).Based on studies reporting hypercholesterolemia as a
risk factor for elevated IOP (Hayreh et al., 1994; Hayreh
et al., 1999; McGwin et al., 2004; Stewart et al., 1996;
Tanaka et al., 2001; Winder, 1977) and on data showing
NOS-2 expression in the optic nerves of rats with
chronic moderately elevated IOP (Shareef et al., 1999),
we wanted to determine the eﬀect of hypercholesterol-
emia on NOS-2 expression in an experimental rat model
of elevated IOP. Hence, the purpose of this study was to
examine the retinal distribution and content of NOS-2
in hypercholesterolemic rats that have undergone epi-
scleral venous occlusion. The extent of retinal damage
was quantiﬁed histologically by measuring RNFL thick-
ness, while NO-mediated cytotoxicity was assessed via
measuring vitreous lipid oxidation in all experimental
groups.2. Materials and methods
2.1. Animals
All experimental protocols conducted on rats were
performed in accordance with the standards established
by the Institutional Animal Care and Use Committee at
Akdeniz University Medical School. Male Wistar rats
weighing 350–450 g were housed in spacious cages and
given food and water ad libitum. Animals were main-
tained at 12 h light-dark cycles and a constant tempera-
ture of 23 ± 1 C at all times. Rats were divided into
four groups of 15 animals each; Group 1: hypercholes-
terolemia, Group 2: hypercholesterolemia + elevated
IOP, Group 3: elevated IOP, Group 4: control.
2.2. Experimental hypercholesterolemia
Hypercholesterolemia was induced by feeding rats
with laboratory chow supplemented with 4% (w/w)
cholesterol, 1% cholic acid and 0.5% thiouracil for 24
weeks (Aliev, Shi, & Perry, 2000). All animals were sac-
riﬁced at the end of 24 weeks and blood samples were
collected via intracardiac puncture. Serum cholesterol
levels were assayed by an automatic analyzer (Hit-
achi-911) using Boehringer-Mannheim kits (Mannheim,
Germany).
2.3. Rat model of elevated IOP
IOP was elevated in rats by unilaterally cauterizing
three episcleral vessels, as previously (Sawada & Neu-
feld, 1999; Shareef, Garcia-Valenzuela, & Salierno,
1995) described. Brieﬂy, rats were anesthetized intraper-
itoneally with a mixture of ketamine hydrochloride
(15 mg/kg), xylazine hydrochloride (0.3 mg/kg) and ace-
promazine (1.5 mg/kg). Episcleral vessels were exposed
by incising the overlying conjunctiva and cauterized
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surgery, on the 7th and 15th days after surgery and once
a month over a 6 month period. A handheld tonometer
(XL-Tonopen, Mentor O and O, Norwell, MA, USA)
was used to measure IOP in rats under light anesthesia
induced by 3 mg/kg acepromazine. One drop of 0.5%
proparacaine hydrochloride was applied to each eye
before readings were obtained. Intraocular pressure
measurements were performed as described in the
instruction manual of the tonometer. The mean IOP
of 5–10 consecutive measurements were recorded. Epi-
scleral venous occlusion in hypercholesterolemic rats
was formed on the 60th day following the initiation of
hypercholesterolemic diet.
2.4. Measurement of retinal nerve ﬁber layer thickness
Globes were enucleated at the end of the experimen-
tal period and sectioned in the vertical meridian. Ob-
tained samples were preﬁxed in 2.2% glutaraldehyde in
0.1 M (pH 7.4) Sorensens phosphate buﬀer for 4 h
and postﬁxed in 1% osmium tetroxide (0.1 M, pH 7.2)
for 1 h. The samples were dehydrated in graded ethyl
alcohol series and embedded in Araldite CY212. Semi-
thin sections were stained with toluidine blue and ob-
served by Nikon opthipot light microscope. RNFL
thickness measurements were standardized by selecting
the same topographic region of the retina in all experi-
mental groups. All measurements were performed at
the central retina, within 1 mm from the optic nerve
margin. Retinal NFL thickness measurements were per-
formed in a double-blinded fashion.
2.5. Measurement of lipid peroxidation
Vitreous was harvested from enucleated globes and
stored at 80 C until analyzed. The liqueﬁed vitreus
was centrifuged at 14,000 · g to remove cellular debris.
Obtained supernatants were transferred to clean tubes
and used for lipid peroxidation analysis. Levels of
MDA, a product of lipid peroxidation, was measured
using the thiobarbituric acid (TBA) ﬂuorometric assay
(Wasowicz, Neve, & Peretz, 1993) with 1,1,3,3-teraeth-
oxypropane as a standard. Brieﬂy, 50 ll of tissue sample
was added to 1 ml distilled water which was then mixed
with equal volumes of 29 mM TBA in acetic acid. After
1 h incubation at >95 C, samples were cooled and 25 ll
of 5 mM HCL was added. The ﬁnal reaction mixture
was extracted with 3.5 ml of n-butanol and the butanol
phase was separated via centrifugation at 1500 · g for
5 min. MDA levels were determined ﬂuorometrically
with excitation and emission wavelengths of 532 nm
and 547 nm, respectively. Protein concentrations in all
samples were measured spectrophotometrically by a
Lowry assay (Lowry, Rosenbrough, & Farr, 1951) with
bovine serum albumin as a standard.2.6. Immunohistochemical staining
Enucleated globe materials were ﬁxed in 10% buﬀered
formalin solutions and incised in transverse plain just
from the center of the globe to obtain two equal parts.
Fixed tissues were washed in phosphate buﬀered saline
(pH 7.4), embedded in paraﬃn and cut into 4-lm sec-
tions. For the peroxidase staining procedure sections
were deparaﬃned, rehydrated and washed with 0.1 M
glycine-Tris solution. To block nonspeciﬁc binding, the
tissue sections were preincubated with 2% goat serum
at room temperature for 30 min. Primary antibody incu-
bations were for 60 min at 25 C using rabbit polyclonal
anti-NOS2 (1:100 dilution, Santa Cruz Biotechnology,
Santa Cruz, CA). After sections were washed they were
immunostained with an avidin–biotin complex kit
(Dako, Glostrup, Denmark) followed by hematoxylin
counterstaining. Negative controls were performed by
replacing the primary antibody with nonimmune serum
followed by immunoperoxidase staining.
Presence of a red–brown colored end-product in the
cytoplasm was indicative of positive staining. Counter-
staining with hematoxylin resulted in a pale to dark blue
coloration of cell nuclei. To obtain a quantitative stan-
dard for NOS-2 immunostaining within the diﬀerent
experimental groups morphometric analysis was per-
formed on all retinal sections by a pathologist blinded
to the experimental conditions. The immunostaining
scores, obtained according to both the percentage and
intensity of positive stained cells, were statistically ana-
lyzed by Sigma Stat (version 2.03) software for windows.
The percentage of the positive stained cells was scored as
follows: 0 = less than 5% of the cells/high powered ﬁeld
(HPF, 40·) are stained, 1 = 5% to less than 30% of cells/
HPF are stained. 2 = 30% to less than 50% of cells/HPF
are stained. 3 = more than 50% of cells/HPF are stained.
The intensity of staining within each counted cell was
also scored as follows: 0 = no staining, 1 = weak stain-
ing (pale red–brown), 2 = moderate staining (red–
brown), 3 = strong staining (dark red–brown). A ﬁnal
immunostaining score was obtained for all sections by
adding the two scores.
2.7. Statistical analysis
The statistical analysis of the obtained data was per-
formed by Sigma Stat (version 2.03) software for win-
dows. The diﬀerences in the MDA values and
immunostaining scores among the diﬀerent groups were
analyzed via Kruskal–Wallis one way analysis of vari-
ance on ranks and all pairwise multiple comparisons
were performed by Dunns Method. The diﬀerences in
the RNFL thickness and cell numbers among the diﬀer-
ent groups were analyzed via one way analysis of vari-
ance and all pairwise multiple comparisons were
performed by Tukey Test. The calculated p values by
1110 _I.Y€ucel et al. / Vision Research 45 (2005) 1107–1114the Sigma Stat (version 2.03) statistical software pro-
gram are given as p < 0.01, p < 0.05 or p < 0.001.Fig. 1. Quantitative histologic measurements of retinal nerve ﬁber
layer thickness in sections stained with toluidine blue. Values represent
mean ± SD (n = 9). * p < 0.01 compared to control and elevated IOP
group.3. Results
3.1. Cholesterol and IOP levels
Cholesterol levels (mean ± SD, n = 15) were signiﬁ-
cantly greater (p < 0.01) in rats fed on cholesterol-
enriched diet than those fed on standard chow
(190 ± 11 mg/dL and 70 ± 5 mg/dL, respectively).
The IOP (mean ± SD, n = 15) measured in control
eyes were 10 ± 1.1 mm Hg. An increase of 7–10 mm Hg
was observed in cauterized eyes compared to contralat-
eral controls. Recorded IOP from cauterized eyes
remained elevated over the 6 month experimental
period.
3.2. Retinal nerve ﬁber layer thickness
RNFL thickness in hypercholesterolemic rats were
signiﬁcantly higher (p < 0.01) than those in the control
and elevated IOP groups (Fig. 1). Calculated values
(mean ± SD, n = 9) of RNFL thickness in the experi-
mental groups were as follows, control: 25.1 ±
1.28 lm, hypercholesterolemia: 31.6 ± 1.26 lm, elevatedFig. 2. Light microscopy of hematoxylin and eosin-stained paraﬃn sections o
are shown from each of the four groups. (A) Control, (B) elevated IOP, (C
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layIOP: 25.3 ± 1.49 lm, hypercholesterolemia + elevated
IOP: 32.1 ± 2.6 lm. No signiﬁcant change in RNFL
thickness was found in the elevated IOP group after
24 weeks following surgery.
3.3. Histologic analysis
Fig. 2 illustrates photomicrographs of retinal cross
sections from representative rats of each of the four dif-
ferent groups. When compared to the control group, the
photoreceptor cell layer (VCL) was less compact and thef rat retinas. Photomicrographs of retinal sections of representative rat
) hypercholesterolemia and (D) hypercholesterolemia + elevated IOP.
er; ONL, outer nuclear layer; VCL, photoreceptor cell layer.
Table 1
Number of cells in the outer nuclear and ganglion cell layer
Group Cells/HPFa
ONLb GCLc
Control 1046 ± 16.8 20.5 ± 0.3
HCd 813 ± 12.7* 16.9 ± 0.4*
Elevated IOPe 1051 ± 13.2 20.7 ± 0.2
HCd + Elevated IOP 804 ± 11.4* 16.6 ± 0.3*
* p < 0.001 compared to control and elevated IOP group.
a HPF—High Power Field (40·).
b ONL—outer nuclear layer.
c GCL—ganglion cell layer.
d HC—hypercholesterolemia.
e IOP—Intraocular pressure.Values represent mean ± SD (n = 15).
Fig. 4. Quantitation of NOS-2 immunostaining. Values represent
mean ± SD (n = 15). The diﬀerences in the immunostaining score
among the diﬀerent groups were analyzed via Kruskal–Wallis one way
analysis of variance on ranks and all pairwise multiple comparisons
were performed by Dunns method. * p < 0.05 compared to HC
(hypercholesterolemia) and ** p < 0.05 compared to elevated IOP and
HC.
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thickness in rats fed on high-cholesterol diet (Fig. 2C
and D). Light microscopic observations of swelling were
conﬁrmed by morphometric analysis which quantiﬁed
the cell numbers in both the ONL and GCL. As shown
in Table 1, the number of cells/high power ﬁeld (40·)
were signiﬁcantly reduced in rats fed on high-cholesterol
diet, p < 0.001. Rats with only elevated IOP showed lit-
tle or no structural abnormality (Fig. 2B).
3.4. Immunohistochemical analysis
Fig. 3 demonstrates the localization of NOS-2 in the
retinal cross sections from representative rats of each of
the four diﬀerent groups. NOS-2 positive staining was
observed throughout the OPL, IPL and GCL in rats
with elevated IOP and/or hypercholesterolemia. TheFig. 3. Immunohistochemistry for NOS-2 in rat retinas. Photomicrographs o
groups. (A) Control, (B) elevated IOP, (C) hypercholesterolemia and (D) hyp
plexiform layer; INL, inner nuclear layer; ONL, outer nuclear layer; VCL, phphotoreceptor cell layer also showed diﬀuse NOS-2
immunostaining in elevated IOP and/or hypercholester-
olemic rats. NOS-2 was not present in eyes of control
rats. The quantitative data obtained for NOS-2 staining
is shown in Fig. 4. When compared to the hypercholes-
terolemic and elevated IOP groups, NOS-2 immuno-
staining score as assessed in the VCL, IPL and GCL,
was signiﬁcantly greater in rats with hypercholesterol-
emia + elevated IOP (p < 0.05). NOS-2 immunostaining
in elevated IOP was also signiﬁcantly greater than in
hypercholesterolemia alone (p < 0.05).f retinal sections of representative rat are shown from each of the four
ercholesterolemia + elevated IOP. GCL, ganglion cell layer; IPL, inner
otoreceptor cell layer. Arrows show regions of NOS-2 immunostaining.
Fig. 5. Vitreous MDA levels. Values represent mean ± SD (n = 6).
* p < 0.05 compared to control and hypercholesterolemia group.
+ p < 0.05 compared to elevated IOP group.
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Vitreous MDA levels (mean ± SD, n = 6) detected in
elevated IOP (3.51 ± 0.31 nmol/mg protein) and hyper-
cholesterolemia + elevated IOP (5.14 ± 1.28 nmol/mg
protein) groups were signiﬁcantly higher (p < 0.05)
than those detected in hypercholesterolemic (1.92 ±
1.43 nmol/mg protein) and control (1.89 ± 0.24 nmol/
mg protein) groups. Vitreous MDA levels in rats with
hypercholesterolemia + elevated IOP were also signiﬁ-
cantly greater (p < 0.05) than in rats with only elevated
IOP (Fig. 5).4. Discussion
This study examined the eﬀect of high cholesterol on
NOS-2 expression, lipid peroxidation and RNFL thick-
ness in rats with elevated IOP. To accomplish this, rats
were fed with laboratory chow supplemented with 4%
(w/w) cholesterol, 1% cholic acid and 0.5% thiouracil
for 24 weeks. This intake of cholesterol resulted in sig-
niﬁcantly elevated levels of serum cholesterol as re-
ported previously (Deepa & Varalakshmi, 2004).
Although previous studies have determined the out-
come of hypercholesterolemia on retinal vascular
changes (Tomida, Tamai, & Matsuda, 2001; Yama-
kawa, Bhutto, & Lu, 2001) in rats, the eﬀect of hyper-
cholesterolemia and increased IOP on rat retinal
morphology and structure has not been reported until
now. The histological analysis of this investigation re-
vealed diverse changes in the retinas of hypercholesterol-
emic rats after a 24-week feeding period. Light
microscopic evaluation revealed that high-cholesterol
caused breaks and discontinuation in focal areas in the
ONL. VCL seemed less compact and the IPL/GCL ap-
peared to be swollen, and increased in thickness in rats
fed on high-cholesterol diet (Fig. 2). RNFL thickness
in hypercholesterolemic rats was also signiﬁcantly high-
er than those in the control and elevated IOP group(Fig. 1). Rats with hypercholesterolemia + elevated
IOP were found to exhibit the most adverse changes in
retinal structure and RNFL thickness suggesting that
combination of hypercholesterolemia and increased
IOP is additive in contributing to the pathogenic
changes observed in the retinas of the reported rat
model.
The observed increase in NOS-2 immunostaining in
experimental rat models with elevated IOP and/or
hypercholesterolemia is consistent with the involvement
of NO neurotoxicity in elevated IOP and hyperlipid-
emia. Reported studies have demonstrated the presence
of NOS-2 in glaucomatous optic nerve heads with con-
sistent staining of nitrotyrosine, suggesting that reactive
nitrogen species may contribute to retinal ganglion cell
death associated with elevated IOP (Liu & Neufeld,
2000; Shareef et al., 1999). Indeed, pharmacological
studies have shown that inhibition of NOS-2 by amino-
guanidine provides neuroprotection of retinal ganglion
cells in a rat model of chronic glaucoma (Neufeld, Saw-
ada, & Becker, 1999). NOS-2 positive staining observed
throughout the OPL, IPL and GCL (Fig. 3) is support-
ive of previous studies which have identiﬁed retinal
NOS-2 production in pigmented epithelial cells (Gou-
reau, Lepoivre, & Becquet, 1993), vascular endothelium
(Chakravarthy, Stitt, & McNally, 1995) and Mu¨ller cells
(Goureau, Hicks, & Courtois, 1994), that span the entire
thickness of the retina.
Hypercholesterolemia plays an important role in
endothelial dysfunction related to cardiovascular dis-
eases. Recent studies have described increased NOS-2
immunoreactivity in aortic endothelial cells of Donryu
rats on a cholesterol-enriched diet (Aliev et al., 2000).
Similarly, increased expression of NOS-2 was reported
in T-lymphocytes and macrophages of cholesterol-fed
rabbits (Esaki, Hayashi, & Muto, 1997). Furthermore,
it was demonstrated that a high-fat diet induced levels
of NOS-2 mRNA in male Sprague-Dawley rats (Kim,
Kang, & Oh, 2002). Increased retinal NOS-2 immunore-
activity observed in rats with hypercholesterol-
emia + elevated IOP (Fig. 4) is supportive of these
ﬁndings and suggests that hypercholesterolemia may
aggravate pathogenic changes in GON by stimulating
the expression of NOS-2 and subsequent NO
production.
Increased vitreous MDA levels detected in rats with
elevated IOP (Fig. 5) is in agreement with previous re-
ports that reveal the occurrence of oxidative stress in
GON (Ferreira, Lerner, & Brunzini, 2004; Izzotti, Sac-
ca, & Cartiglia, 2003). Oxygen radicals exert their cyto-
toxic eﬀects, in part, by causing peroxidation of
membrane lipids, which results in increased membrane
permeability and the loss of membrane integrity (Free-
man & Crapo, 1982). Increased cholesterol levels en-
hance the production of reactive oxygen species (ROS)
and provoke cellular injury (White, Brock, & Chang,
Fig. 6. The additive eﬀects of hypercholesterolemia and elevated IOP
on NOS-2 expression.
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platelet-activating factor, which in turn increases the
synthesis and release of inﬂammatory cytokines known
to stimulate polymorph nuclear leukocytes to produce
ROS (Prasad, Kalra, & Lee, 1994). The signiﬁcant in-
crease observed in vitreous MDA levels in rats with
hypercholesterolemia + elevated IOP (Fig. 5) suggests
that hypercholesterolemia is additive in contributing to
oxidative stress and related pathogenic changes ob-
served in the retinas of rats with elevated IOP.
In summary, the present data illustrates that both ele-
vated IOP and hypercholesterolemia augments NOS-2
expression and leads to increased lipid oxidation in rats.
Although these ﬁndings show increased IOP and choles-
terol levels have additive eﬀects on aforementioned
parameters, it is unknown if they are related. Neverthe-
less, hypercholesterolemia is a risk factor in the develop-
ment of GON (Hayreh et al., 1994; McGwin et al., 2004;
Stewart et al., 1996; Tanaka et al., 2001; Winder, 1977)
and as depicted in Fig. 6, data herein suggest that in-
creased circulating cholesterol may exacerbate disease
progression by inducing NOS-2 expression and elevating
oxidant tissue injury.Acknowledgment
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